A low factor V activity test means the blood has reduced working factor V, a clotting protein needed to build a stable fibrin clot after injury. Factor V sits in the common pathway of coagulation, so a true deficiency often affects both prothrombin time (PT) and activated partial thromboplastin time (aPTT). The result matters most when it appears with easy bruising, nosebleeds, heavy menstrual bleeding, bleeding after surgery or dental work, liver disease, disseminated intravascular coagulation (DIC), or an abnormal mixing study. Low factor V activity is rare when inherited, but it also occurs as an acquired problem from liver dysfunction, factor V inhibitors, severe illness, or clotting factor consumption. The test result does not diagnose the cause by itself. It needs interpretation alongside PT, INR, aPTT, fibrinogen, platelet count, liver markers, medication history, bleeding history, and sometimes genetic or inhibitor testing.
- Low factor V activity usually points to reduced factor V function, not factor V Leiden, which is a clot-risk mutation.
- Many laboratories report factor V activity as a percentage of normal, often with a reference range near 50% to 150%, but each lab sets its own range.
- Severe inherited factor V deficiency is very rare and is often defined as activity below 1% of normal.
- Low factor V commonly prolongs both PT and aPTT while thrombin time stays normal unless another clotting problem is present.
- Bleeding risk rises with very low activity, but symptoms vary; some people bleed more or less than the number suggests.
- Urgent care is needed for heavy uncontrolled bleeding, black stools, blood in urine, severe headache, neurological symptoms, or bleeding after injury while clotting tests are abnormal.
Table of Contents
- What Low Factor V Activity Means
- How the Test Is Interpreted
- Main Causes of Low Factor V Activity
- Bleeding Risk and Symptoms
- Factor V Deficiency vs Factor V Leiden
- Follow-Up Tests After a Low Result
- Treatment and Planning
- Common Mistakes When Reading Results
What Low Factor V Activity Means
Low factor V activity means the tested plasma forms clots with less factor V function than expected. Factor V is a helper protein, not an enzyme. Once activated, it helps factor Xa convert prothrombin into thrombin. Thrombin then helps turn fibrinogen into fibrin, which strengthens the clot.
Factor V is part of the common pathway, shared by the PT and aPTT systems. That is why a significant factor V deficiency often shows up as both a prolonged PT and a prolonged aPTT. A broader coagulation panel often gives the first clue before the factor V activity assay confirms the specific abnormality.
Most laboratories report factor V activity as a percentage. A result of 100% means the sample behaves like average normal plasma in that assay. A result of 25% means the measured clotting activity is about one quarter of that reference activity. Many labs use a reference interval near 50% to 150%, but the exact range varies by method, reagent, age group, and laboratory.
A low value does not always mean a person has a lifelong bleeding disorder. Factor V activity drops for several reasons, including inherited factor V deficiency, acquired inhibitors, severe liver disease, DIC, massive bleeding, large-volume transfusion, or sample problems. The clinical meaning comes from the pattern: how low the activity is, whether PT and aPTT are prolonged, whether other clotting factors are low, and whether bleeding is present.
The result also needs separation from factor V Leiden. Factor V deficiency causes reduced factor V activity and a bleeding tendency. Factor V Leiden changes factor V so it resists inactivation by activated protein C and raises clot risk. The names sound similar, but the conditions point in opposite clinical directions.
How the Test Is Interpreted
A factor V activity result is interpreted with the laboratory reference range and the reason the test was ordered. Testing often follows unexplained prolonged PT and aPTT, unexpected bleeding, a suspected inherited bleeding disorder, liver disease evaluation, or investigation of an acquired clotting inhibitor.
Typical activity categories
The categories below are commonly used for factor V deficiency severity. They are not perfect bleeding predictors, but they help organize the result.
| Factor V activity | Common category | Usual meaning |
|---|---|---|
| About 50% to 150% | Usually within range | Factor V function is usually adequate, depending on the lab range. |
| Above 10% but below the lab range | Mild deficiency | Bleeding is often mild or absent, but surgery, childbirth, trauma, or dental work can reveal a problem. |
| 1% to 10% | Moderate deficiency | Bleeding risk is higher, especially with procedures or injury. |
| Below 1% | Severe deficiency | Serious bleeding is possible, including internal bleeding, though symptoms still vary between individuals. |
A mildly low value, such as 35% or 45%, deserves attention but does not carry the same meaning as activity below 5%. A very low value, especially below 10%, needs faster follow-up, particularly when PT and aPTT are prolonged or the person has active bleeding.
Expected clotting test pattern
Factor V deficiency usually affects both the prothrombin time test and the aPTT test. That pattern happens because factor V is in the common pathway, downstream from the separate extrinsic and intrinsic pathways.
A typical pattern looks like this:
- PT: prolonged
- INR: often increased because INR is derived from PT
- aPTT: prolonged
- Thrombin time: usually normal
- Fibrinogen: usually normal in isolated factor V deficiency
- Platelet count: usually normal in inherited isolated factor V deficiency
If fibrinogen is low, thrombin time is prolonged, platelets are low, and D-dimer is high, the pattern suggests a broader clotting disturbance such as DIC rather than isolated factor V deficiency. If only PT is prolonged, factor VII deficiency, vitamin K deficiency, warfarin effect, or early liver dysfunction becomes more likely than isolated factor V deficiency.
Why the number and symptoms may not match
Factor V activity does not predict bleeding as neatly as some clotting factor tests do. Part of factor V is stored inside platelets, and platelet factor V contributes to clot formation at injured tissue. Two people with similar plasma factor V activity can have different bleeding histories.
A person with very low activity and no major bleeding still needs specialist guidance before surgery, childbirth, invasive procedures, or anticoagulant use. A person with a moderately low result and a strong bleeding history also deserves careful evaluation, even when the number does not look severe.
Main Causes of Low Factor V Activity
Low factor V activity comes from either too little usable factor V, factor V that does not work correctly, increased consumption of clotting factors, reduced liver production, or an inhibitor that blocks factor V.
Inherited factor V deficiency
Inherited factor V deficiency is also called Owren disease or parahemophilia. It is rare and usually follows an autosomal recessive pattern, meaning a person with severe disease typically inherits abnormal copies of the F5 gene from both parents. Carriers often have roughly half-normal factor V activity and no major symptoms.
Inherited deficiency can be quantitative or qualitative. In quantitative deficiency, the body makes too little factor V. In qualitative deficiency, the amount may be closer to normal, but the protein does not work properly. Either pattern can lower activity.
Symptoms often begin in childhood in severe cases. Mild forms sometimes appear only after dental extraction, surgery, heavy menstrual bleeding, childbirth, or trauma. A family history of bleeding, consanguinity, or a known rare bleeding disorder raises suspicion, but absence of family history does not rule it out.
Combined factor V and factor VIII deficiency
Combined factor V and factor VIII deficiency is a separate inherited disorder. It does not usually come from mutations in the F5 gene itself. It usually involves genes that help move factor V and factor VIII through the cell before secretion into the blood.
This condition lowers both factor V and factor VIII activity, often into a mild-to-moderate range. The lab pattern can include prolonged PT and aPTT, and bleeding symptoms can include bruising, nosebleeds, heavy menstrual bleeding, and surgical bleeding. Measuring factor VIII activity helps separate combined deficiency from isolated factor V deficiency.
Liver disease
The liver makes most circulating factor V. Significant liver dysfunction can lower factor V activity along with other clotting factors, albumin, bilirubin changes, and abnormal liver enzymes. A liver function test panel helps place a low factor V result in context.
Factor V is especially useful because vitamin K deficiency and warfarin mainly affect vitamin K-dependent clotting factors: II, VII, IX, and X. Factor V is not vitamin K-dependent. When PT is prolonged and factor V is low, impaired liver synthesis becomes more concerning than isolated vitamin K deficiency. When PT is prolonged and factor V is normal, vitamin K deficiency or warfarin effect stays higher on the list.
Disseminated intravascular coagulation
DIC is a serious condition in which widespread clotting activation consumes clotting factors and platelets. It can occur with severe infection, trauma, cancer, obstetric emergencies, severe inflammation, or shock. Factor V activity can fall because the body is using up clotting proteins faster than it replaces them.
DIC usually produces a broad abnormal pattern: prolonged PT and aPTT, low or falling fibrinogen, low platelets, high D-dimer, and clinical illness. A low factor V result in this setting points to a system-wide coagulation problem rather than an isolated inherited factor deficiency.
Acquired factor V inhibitors
An acquired factor V inhibitor is an antibody that interferes with factor V. It is rare but important because it can cause sudden severe bleeding in someone with no lifelong bleeding history. Reported triggers include surgery, exposure to bovine thrombin products used in some surgical settings, antibiotics, infections, autoimmune disease, cancer, transfusion, and sometimes no clear trigger.
The usual clue is a new, unexplained prolongation of both PT and aPTT with very low factor V activity. A mixing study helps separate a simple deficiency from an inhibitor, although some inhibitors act slowly and require incubation for detection.
Massive bleeding, transfusion, and critical illness
Large-volume blood loss, plasma dilution from fluids, massive transfusion, and critical illness can lower clotting factor levels. Factor V activity may be one of several abnormalities rather than the only problem. In these cases, doctors treat the clinical situation and monitor repeated coagulation tests rather than relying on a single factor V value.
Bleeding Risk and Symptoms
Bleeding risk depends on factor V activity, bleeding history, other lab results, age, medications, planned procedures, liver function, platelet count, and whether the deficiency is inherited or acquired.
Mild deficiency often causes no daily symptoms. Bleeding may appear only during a challenge, such as wisdom tooth removal, tonsil surgery, major dental work, childbirth, miscarriage, injury, or an operation. Moderate and severe deficiency raise the chance of spontaneous or excessive bleeding, but the relationship is uneven.
Common bleeding symptoms include:
- Frequent or hard-to-stop nosebleeds
- Easy bruising or large bruises after minor bumps
- Gum bleeding, especially after brushing or dental work
- Heavy or prolonged menstrual bleeding
- Prolonged bleeding after cuts, surgery, childbirth, or trauma
- Blood in urine
- Black or bloody stools
- Vomiting blood or coffee-ground material
- Joint, muscle, or soft tissue bleeding in more severe cases
Severe bleeding warning signs need urgent medical care. These include severe headache, confusion, weakness on one side, vision changes, fainting, chest pain, shortness of breath, heavy bleeding that does not stop with pressure, abdominal swelling with pain, black stools, large-volume rectal bleeding, vomiting blood, or blood in urine with clots.
Newborns and infants with severe factor V deficiency need special attention because bleeding can occur early in life. Intracranial bleeding is uncommon but dangerous. Warning signs in an infant include seizures, unusual sleepiness, a bulging fontanelle, poor feeding, repeated vomiting, pallor, or unexplained swelling.
Medication use changes the risk picture. Aspirin, clopidogrel, warfarin, heparin, direct oral anticoagulants, nonsteroidal anti-inflammatory drugs, and some supplements can worsen bleeding or complicate interpretation. A low factor V result should always be reviewed with a full medication and supplement list.
Factor V Deficiency vs Factor V Leiden
Factor V deficiency and factor V Leiden are different conditions with different risks. Confusing them leads to unnecessary worry or unsafe assumptions.
Factor V deficiency means factor V activity is low or factor V is blocked. The main clinical concern is bleeding. PT and aPTT may be prolonged when activity is significantly reduced.
Factor V Leiden is a mutation that makes factor V resistant to activated protein C, one of the body’s natural brakes on clotting. The main concern is venous thrombosis, such as deep vein thrombosis or pulmonary embolism. Routine PT and aPTT are often normal. Screening often involves an activated protein C resistance test or genetic testing.
| Feature | Factor V deficiency | Factor V Leiden |
|---|---|---|
| Main issue | Too little working factor V or blocked factor V | Factor V resists inactivation by activated protein C |
| Main risk | Bleeding | Blood clots in veins |
| Typical PT/aPTT pattern | Both can be prolonged | Usually normal |
| Main tests | Factor V activity, mixing study, inhibitor testing | Activated protein C resistance or F5 Leiden genetic test |
| Usual treatment focus | Preventing and treating bleeding | Managing clot risk when clinically needed |
A person can theoretically carry factor V Leiden and also have another bleeding problem, but one result does not imply the other. A low factor V activity result should not be interpreted as proof of factor V Leiden.
Follow-Up Tests After a Low Result
Follow-up testing aims to answer four questions: Is the low value real? Is it isolated? Is there an inhibitor? Is the person at risk during bleeding or procedures?
A clinician usually starts by reviewing the original reason for testing, bleeding history, medications, liver disease history, family history, and the exact laboratory pattern. Repeat testing is common when the result is unexpected, mildly low, or inconsistent with the clinical picture.
Useful follow-up tests include:
- PT, INR, aPTT, thrombin time, fibrinogen, and D-dimer
- Complete blood count with platelet count
- Factor II, VII, VIII, X, and sometimes XI activity
- Factor V antigen, when available, to separate low amount from poor function
- Mixing study for prolonged PT and aPTT
- Factor V inhibitor testing, often with Bethesda-style methods
- Liver enzymes, bilirubin, albumin, and kidney function tests
- Tests for DIC when the person is acutely ill
- Genetic testing for inherited deficiency in selected cases
The factor pattern helps narrow the cause. Low factor V with normal factor VIII supports isolated factor V deficiency. Low factor V and low factor VIII suggests combined factor V and VIII deficiency or a broader illness. Low factor V with multiple other liver-made factors and abnormal liver markers points toward impaired liver synthesis. Low factor V with low fibrinogen, low platelets, and high D-dimer supports DIC or severe systemic coagulation activation.
A mixing study is especially useful when PT and aPTT are prolonged. In this test, patient plasma is mixed with normal plasma. Correction suggests a missing factor because the normal plasma supplies what is lacking. Failure to correct suggests an inhibitor. Some factor V inhibitors are time-dependent, so laboratories may incubate the mixture and check correction again later.
Pre-analytical issues also matter. Underfilled citrate tubes, clotted specimens, delayed processing, heparin contamination, and improper handling can distort coagulation results. When the lab pattern does not fit the person’s condition, repeating the sample under careful collection conditions prevents mislabeling someone with a rare disorder.
Treatment and Planning
Treatment depends on the cause, the factor V activity level, the bleeding history, and whether bleeding is active or a procedure is planned. People without active bleeding often need no immediate treatment, but they still need a plan for surgery, childbirth, dental work, trauma, or anticoagulant decisions.
There is no widely available factor V concentrate. Fresh frozen plasma is the main replacement product for clinically important inherited factor V deficiency because it contains factor V. Platelet transfusion can help in selected cases because platelets carry factor V in their granules. Antifibrinolytic medicines, such as tranexamic acid, are often useful for mucosal bleeding, dental procedures, nosebleeds, and heavy menstrual bleeding when appropriate.
For inherited factor V deficiency, care often focuses on prevention. A hematologist may recommend a target factor V level before surgery or invasive procedures. Severe deficiency usually requires a written bleeding plan, medical identification, and clear instructions for emergency departments.
For acquired factor V inhibitors, treatment has two parts: control bleeding and reduce or eliminate the inhibitor. Bleeding control may involve plasma, platelet transfusion, bypassing agents, or other blood products depending on severity and specialist guidance. Inhibitor treatment may involve corticosteroids, intravenous immunoglobulin, rituximab, cyclophosphamide, plasma exchange, or treating an underlying trigger such as infection, cancer, autoimmune disease, or a suspected medication reaction.
For liver disease or DIC, treatment targets the underlying condition. Replacing plasma without treating sepsis, severe liver failure, shock, or obstetric complications will not solve the cause. In these cases, factor V activity helps show severity and clotting factor production or consumption, but management centers on the broader illness.
People with low factor V activity should tell clinicians before:
- Surgery or biopsy
- Dental extraction or deep dental procedures
- Pregnancy, labor, or postpartum planning
- Starting anticoagulants or antiplatelet medicines
- Endoscopy with possible biopsy
- Injections into joints or deep tissues
- Contact sports or activities with high injury risk when deficiency is severe
Heavy menstrual bleeding deserves specific care. Treatment may involve tranexamic acid, hormonal therapy, iron testing, anemia treatment, and a bleeding disorder plan. A low hemoglobin result can reveal chronic blood loss even when bleeding feels “normal” to the person experiencing it.
Pregnancy planning should involve hematology and obstetrics when factor V activity is clearly low or there is a known factor V disorder. Delivery planning often includes recent factor levels, blood product availability, anesthesia planning, postpartum hemorrhage prevention, and newborn evaluation when an inherited disorder is possible.
Common Mistakes When Reading Results
A low factor V activity result is easy to misread when it is separated from the rest of the coagulation workup.
One common mistake is assuming low factor V means factor V Leiden. Factor V Leiden is usually a clot-risk condition, while low factor V activity usually raises bleeding concern. The tests, meaning, and treatment are different.
Another mistake is treating the reference range as universal. Factor V activity ranges vary by lab. A result just below one lab’s range may not mean the same thing as a result far below range or below 10%. Always compare the value with the reporting laboratory’s interval.
A third mistake is assuming vitamin K deficiency explains every prolonged PT. Vitamin K deficiency lowers factors II, VII, IX, and X, but not factor V. Low factor V pushes interpretation toward liver synthesis problems, DIC, factor consumption, or factor V-specific disorders.
A fourth mistake is ignoring the platelet count and fibrinogen. Isolated inherited factor V deficiency often has normal platelets and fibrinogen. Low platelets plus low fibrinogen and high D-dimer points toward a broader consumption process.
A fifth mistake is overlooking medications. Aspirin and other antiplatelet medicines do not lower factor V activity, but they worsen bleeding symptoms. Anticoagulants can alter PT or aPTT and confuse the initial pattern. The medication list is part of the test interpretation, not a side detail.
A sixth mistake is underestimating a new abnormal result in an older adult with bleeding. New severe prolongation of PT and aPTT with low factor V activity can signal an acquired inhibitor. This situation needs prompt hematology involvement, especially with bleeding in urine, stool, skin, soft tissues, or after a procedure.
A seventh mistake is assuming no symptoms means no risk. Some people with low factor V activity have little daily bleeding but bleed during surgery or trauma. A documented low result should be shared before procedures so the team can prepare.
References
- Diagnosis and management of the rare coagulation disorders: A UKHCDO Guideline on behalf of BCSH 2024 (Guideline)
- Factor V Deficiency 2025 (Review)
- Factor V variants in bleeding and thrombosis 2024 (Review)
- Clinical, Laboratory, Molecular, and Reproductive Aspects of Combined Deficiency of Factors V and VIII 2025 (Review)
- A case of unusual acquired factor V deficiency 2023 (Case Report)
- Congenital coagulation factor V deficiency with intracranial hemorrhage 2022 (Review)
Disclaimer
This article is educational and does not replace care from a qualified medical professional. Low factor V activity can reflect a rare inherited bleeding disorder, liver disease, DIC, an acquired inhibitor, medication-related complexity, or a sample issue, so interpretation should be individualized. Seek urgent medical care for severe, persistent, internal, neurological, or post-injury bleeding.
